All 50 states, Washington, D.C., and four U.S. territories have signed on to a $7.4 billion settlement with Purdue Pharma, the maker of OxyContin. The deal has reportedly also been approved by the Sackler family, owners of Purdue. If finalized, the settlement will go toward resolving thousands of victim lawsuits against Purdue. It will also help fund addiction treatment, prevention and recovery programs. Under the deal, the Sacklers will lose control over Purdue. The deal also does not shield the Sacklers from future opioid lawsuits, which they had previously fought for. Over 850,000 people have died from opioid-related overdoses in the United States since 1999.